Lung Cancer

Choosing the Right Therapy for Patients with NSCLC

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data. Read More ›

Immunotherapies and Lung Cancer

Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice. Read More ›

My Practice: Roles and Responsibilities

Dr. Edward Garon explains how he discusses immunotherapies with patients. Read More ›

Challenges in Managing Toxicities

Dr. Edward Garon describes how staff at his practice interacts with patients. Read More ›

E-Cigarettes: The New Threat to Public Health

Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity. Read More ›

By Meg Barbor, MPH

TON - March 2017, Vol 10, No 2

It is now widely known that light cigarettes are no safer than regular cigarettes and were only marketed in an attempt to undermine smokers’ wishes to quit smoking. According to Charlotta Pisinger, PhD, MPH, the tobacco industry is now using the same tactic with electronic cigarettes (e-cigarettes). Read More ›

Managing Immune-Related Toxicities in Patients with Lung Cancer

By Meg Barbor, MPH

TON - March 2017, Vol 10, No 2

Toxicities related to immunotherapies approved for the treatment of patients with non–small-cell lung cancer (NSCLC) are uncommon but can be life-threatening. Read More ›

Medical Nutrition Therapy Shows Promise in Patients with Lung Cancer

By Meg Barbor, MPH

TON - November 2016, Vol 9, No 6

The prevalence of malnutrition in patients with lung cancer is particularly high, but early and intensive individualized dietary counseling can improve quality of life for these patients and decrease their chances of experiencing significant weight loss. Read More ›

Walking Reduces Markers of Inflammation and Death in Male Smokers with Lung Cancer

By Caroline Helwick